AbbVie

AWARE: A Phase 2 Multiple Dose, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer’s Disease.

Status: Active

Sponsor: AbbVie

keyboard_arrow_up